Chimeric Therapeutics Ltd
ASX:CHM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chimeric Therapeutics Ltd
ASX:CHM
|
AU |
|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
CN |
|
Dixon Technologies (India) Ltd
BSE:540699
|
IN |
|
Banco Santander Mexico SA Institucion de Banca Multiple Grupo Financiero Santander Mexico
BMV:BSMXB
|
MX |
|
R
|
Reborn Coffee Inc
NASDAQ:REBN
|
US |
|
Ermenegildo Zegna NV
NYSE:ZGN
|
IT |
|
H
|
Human Creation Holdings Inc
TSE:7361
|
JP |
|
Skillz Inc
NYSE:SKLZ
|
US |
|
H
|
Hui Lyu Ecological Technology Groups Co Ltd
SZSE:001267
|
CN |
|
C
|
CICT Mobile Communication Technology Co Ltd
SSE:688387
|
CN |
|
A-Mark Precious Metals Inc
NASDAQ:AMRK
|
US |
|
G
|
Gulshan Polyols Ltd
NSE:GULPOLY
|
IN |
|
K
|
KAISA JiaYun Technology Inc
SZSE:300242
|
CN |
Chimeric Therapeutics Ltd
Chimeric Therapeutics Ltd. develops Chlorotixin CAR-T technology based cell therapies for the curation of solid tumors. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. The firm's technology known as CLTX-CAR T, uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. The CAR T cell is an immune T cell taken from a patient’s blood which is sent to a lab where it is re-programmed to become a charged guided missile, to seek out a specific target on the surface of a cancer cell.
Chimeric Therapeutics Ltd. develops Chlorotixin CAR-T technology based cell therapies for the curation of solid tumors. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. The firm's technology known as CLTX-CAR T, uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. The CAR T cell is an immune T cell taken from a patient’s blood which is sent to a lab where it is re-programmed to become a charged guided missile, to seek out a specific target on the surface of a cancer cell.
